Live Pharma Import data of Philippines imports from italy under HS Code 30 via Port Manila-int'l-container-port , our Philippines customs import data reports include date, value, quantity, product description, HS code, port, country, and Philippines pharma importers data
| Date |
HS Code |
Product Description |
Origin Country |
Custom Name |
QTY. |
Unit |
Weight |
Importer Name |
|---|---|---|---|---|---|---|---|---|
| 2024-11-25 00:00:00 |
30049099000
|
19 PALLETS STC, 48,832 BOXES OF FLUIMUCIL 5FF 3ML (ACETYLCYSTEINE) HARMLESS PHARMACEUTICALS, LOT NO: 28007284,MD DT: 07-2024 ED DT: 07-2029 | ITALY | Manila Int'l Container Port | 2114.41 | Kilogram | 87646.085222431 | Importer Name |
2024-11-25 00:00:00
19 PALLETS STC, 48,832 BOXES OF FLUIMUCIL 5FF 3ML (ACETYLCYSTEINE) HARMLESS PHARMACEUTICALS, LOT NO: 28007284,MD DT: 07-2024 ED DT: 07-2029
2114.41
Kilogram
87646.085222431
The database includes shipment-level information such as shipment date, HS code, product description, quantity, value, port details, country of origin & destination, & importer-exporter information for accurate trade analysis of products under HS code 30 for Philippines pharma imports from Thailand via Port Manila-int'l-container-port.
Port Manila-int'l-container-port typically refers to a port that is used for handling and forwarding shipments into Philippines, making it important for tracking inland and cross-border trade flows.
It helps businesses understand sourcing patterns, evaluate supplier performance, track pricing trends, and identify demand for pharma products, enabling better decision-making for trade and market expansion for Philippines pharma imports from italy under HS code 30 via Port Manila-int'l-container-port.
Businesses can identify key importers, evaluate supplier competitiveness, track pricing trends, and analyze demand for specific rubber products to make strategic sourcing and expansion decisions.
Importers, exporters, traders, manufacturers, and market analysts can use this data to understand trade patterns, optimize supply chains, identify potential partners, and gain a competitive advantage in the pharma market.
